04-12-2025 17:56 via drugs.com

Appropriate Duration of ADT in Prostate Cancer Depends on Risk

THURSDAY, Dec. 4, 2025-- Increasing duration of androgen deprivation therapy (ADT) is beneficial for some men with prostate cancer, while those with lower risk cancer may not need long-term ADT, according to research published online Nov. 25 in...

Guidelines Expanded for Cervical Cancer Screening to Include Self-Swab HPV Test

Rocatinlimab Yields Significant Improvements in Atopic Dermatitis

Immediate Neuro-Rehabilitative Therapy After TBI Cuts Alzheimer Disease Risk

Polyphenol-Rich Foods Tied to Better Cardiovascular Health

Most Speakers at FDA Advisory Committee Meetings Support Drug Approval

Medical Professionals Lack Knowledge on Health Implications of Adoption

Home Hospital Care Beneficial for Acute Illness in Rural Settings

AES: First Seizure Clinic Speeds Time to Diagnosis With Pediatric Epilepsy

RSNA: Long-Term Exposure to Air Pollution Linked to More Advanced CAD

Inaugural Report Describes Trends in Pediatric Cancer in U.S.

Corticosteroids Probably Cut Short-Term Mortality in Severe Pneumonia, ARDS

Poorer Nutritional Outcomes Seen for Older Adults Who Eat Alone

Oral Engasertib Safe for Hereditary Hemorrhagic Telangiectasia

Tezepelumab Can Help Reduce Oral Corticosteroid Use in Severe Uncontrolled Asthma

Desktop versie

Appropriate Duration of ADT in Prostate Cancer Depends on Risk

Pharmaceutical Industry news